Background: To the Editor, Serology may offer valuable information during COVID-19 pandemic; however, published papers mainly reported the results of symptomatic patients having positive RT-PCR on upper respiratory tract specimens [1]. More studies are needed to address whether asymptomatic patients, or patients with chest imaging compatible with COVID-19 but negative RT-PCR, have different antibody response that could influence assays performances. We wanted to share our data from Turkey where 4,323,596 COVID-19 cases were detected out of 44,087,628 PCR tests by April 20, 2021 but there are only a couple of published studies about serodiagnosis of the infection.
Discussion: The authors have no funding source for the study. The authors have no conflicts of interest to declare.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3906/sag-2104-242 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!